{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T02:32:01Z","timestamp":1791513121148,"version":"4.3.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T00:00:00Z","timestamp":1646352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T00:00:00Z","timestamp":1646352000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000615","name":"fight for sight uk","doi-asserted-by":"publisher","award":["1831"],"award-info":[{"award-number":["1831"]}],"id":[{"id":"10.13039\/501100000615","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"medical research council","doi-asserted-by":"publisher","award":["MR\/R024952\/1"],"award-info":[{"award-number":["MR\/R024952\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Inherited vitreoretinopathies arise as a consequence of congenital retinal vascularisation abnormalities. They represent a phenotypically and genetically heterogeneous group of disorders that can have a major impact on vision. Several genes encoding proteins and effectors of the canonical Wnt\/\u03b2-catenin pathway have been associated and precise diagnosis, although difficult, is essential for proper clinical management including syndrome specific management where appropriate. This work aimed to investigate the molecular basis of disease in a single proband born to consanguineous parents, who presented with microphthalmia, persistent foetal vasculature, posterior lens vacuoles, vitreoretinal dysplasia, microcephaly, hypotelorism and global developmental delay, and was registered severely visually impaired by 5\u00a0months of age.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Extensive genomic pre-screening, including microarray comparative genomic hybridisation and sequencing of a 114 gene panel associated with cataract and congenital ophthalmic disorders was conducted by an accredited clinical laboratory. Whole exome sequencing (WES) was undertaken on a research basis and in vitro TOPflash transcriptional reporter assay was utilised to assess the impact of the putative causal variant.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In the proband, WES revealed a novel, likely pathogenic homozygous mutation in the cadherin-associated protein beta-1 gene (<jats:italic>CTNNB1),<\/jats:italic> c.884C&gt;G; p.(Ala295Gly), which encodes a co-effector molecule of the Wnt\/\u03b2-catenin pathway. The proband\u2019s parents were shown to be heterozygous carriers but ophthalmic examination did not detect any abnormalities. Functional assessment of the missense variant demonstrated significant reduction of \u03b2-catenin activity.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This is the first report of a biallelic disease-causing variation in <jats:italic>CTNNB1<\/jats:italic>. We conclude that this biallelic, transcriptional inactivating mutation of <jats:italic>CTNNB1<\/jats:italic> causes a severe, syndromic form of microphthalmia, persistent foetal vasculature and vitreoretinal dysplasia that results in serious visual loss in infancy.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-022-02239-3","type":"journal-article","created":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T13:28:36Z","timestamp":1646400516000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Bi-allelic mutation of CTNNB1 causes a severe form of syndromic microphthalmia, persistent foetal vasculature and vitreoretinal dysplasia"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1235-4303","authenticated-orcid":false,"given":"Rachel L.","family":"Taylor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla Sanjuro","family":"Soriano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denisa","family":"Dzulova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Ashworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgina","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodora","family":"Gale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I. Christopher","family":"Lloyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris F.","family":"Inglehearn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmel","family":"Toomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Douzgou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme C.","family":"Black","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,4]]},"reference":[{"issue":"12","key":"2239_CR1","doi-asserted-by":"publisher","first-page":"2714","DOI":"10.1038\/emboj.2012.150","volume":"31","author":"T Valenta","year":"2012","unstructured":"Valenta T, Hausmann G, Basler K. The many faces and functions of beta-catenin. EMBO J. 2012;31(12):2714\u201336.","journal-title":"EMBO J"},{"issue":"7","key":"2239_CR2","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1002\/ijc.26102","volume":"129","author":"Y Fu","year":"2011","unstructured":"Fu Y, Zheng S, An N, Athanasopoulos T, Popplewell L, Liang A, et al. beta-catenin as a potential key target for tumor suppression. Int J Cancer. 2011;129(7):1541\u201351.","journal-title":"Int J Cancer"},{"issue":"6","key":"2239_CR3","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1002\/ajmg.a.36484","volume":"164A","author":"E Dubruc","year":"2014","unstructured":"Dubruc E, Putoux A, Labalme A, Rougeot C, Sanlaville D, Edery P. A new intellectual disability syndrome caused by CTNNB1 haploinsufficiency. Am J Med Genet A. 2014;164A(6):1571\u20135.","journal-title":"Am J Med Genet A"},{"issue":"1","key":"2239_CR4","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00439-014-1498-1","volume":"134","author":"A Kuechler","year":"2015","unstructured":"Kuechler A, Willemsen MH, Albrecht B, Bacino CA, Bartholomew DW, van Bokhoven H, et al. De novo mutations in beta-catenin (CTNNB1) appear to be a frequent cause of intellectual disability: expanding the mutational and clinical spectrum. Hum Genet. 2015;134(1):97\u2013109.","journal-title":"Hum Genet"},{"issue":"6114","key":"2239_CR5","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1126\/science.1227764","volume":"338","author":"BJ O'Roak","year":"2012","unstructured":"O\u2019Roak BJ, Vives L, Fu W, Egertson JD, Stanaway IB, Phelps IG, et al. Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders. Science. 2012;338(6114):1619\u201322.","journal-title":"Science"},{"issue":"4","key":"2239_CR6","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1172\/JCI70372","volume":"124","author":"V Tucci","year":"2014","unstructured":"Tucci V, Kleefstra T, Hardy A, Heise I, Maggi S, Willemsen MH, et al. Dominant beta-catenin mutations cause intellectual disability with recognizable syndromic features. J Clin Invest. 2014;124(4):1468\u201382.","journal-title":"J Clin Invest"},{"issue":"1","key":"2239_CR7","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1167\/iovs.18-25142","volume":"60","author":"W Sun","year":"2019","unstructured":"Sun W, Xiao X, Li S, Jia X, Wang P, Zhang Q. Germline mutations in CTNNB1 associated with syndromic FEVR or Norrie disease. Invest Ophthalmol Vis Sci. 2019;60(1):93\u20137.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"20","key":"2239_CR8","doi-asserted-by":"publisher","first-page":"e6914","DOI":"10.1097\/MD.0000000000006914","volume":"96","author":"N Li","year":"2017","unstructured":"Li N, Xu Y, Li G, Yu T, Yao RE, Wang X, et al. Exome sequencing identifies a de novo mutation of CTNNB1 gene in a patient mainly presented with retinal detachment, lens and vitreous opacities, microcephaly, and developmental delay: Case report and literature review. Medicine (Baltimore). 2017;96(20):e6914.","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"2239_CR9","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.ajhg.2017.05.001","volume":"100","author":"ES Panagiotou","year":"2017","unstructured":"Panagiotou ES, Sanjurjo Soriano C, Poulter JA, Lord EC, Dzulova D, Kondo H, et al. Defects in the cell signaling mediator beta-catenin cause the retinal vascular condition FEVR. Am J Hum Genet. 2017;100(6):960\u20138.","journal-title":"Am J Hum Genet"},{"key":"2239_CR10","doi-asserted-by":"crossref","unstructured":"Kramer GD, Say EA, Shields CL. Simultaneous novel mutations of LRP5 and TSPAN12 in a case of familial exudative vitreoretinopathy. J Pediatr Ophthalmol Strabismus. 2016;53 Online:e1\u20135.","DOI":"10.3928\/01913913-20151215-01"},{"issue":"11","key":"2239_CR11","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1007\/s00417-018-4076-8","volume":"256","author":"Y Li","year":"2018","unstructured":"Li Y, Peng J, Li J, Zhang Q, Li J, Zhang X, et al. The characteristics of digenic familial exudative vitreoretinopathy. Graefes Arch Clin Exp Ophthalmol. 2018;256(11):2149\u201356.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"7","key":"2239_CR12","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1111\/aos.13411","volume":"95","author":"P Schatz","year":"2017","unstructured":"Schatz P, Khan AO. Variable Familial Exudative Vitreoretinopathy in a family harbouring variants in both FZD4 and TSPAN12. Acta Ophthalmol. 2017;95(7):705\u20139.","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"2239_CR13","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1097\/ICB.0b013e31827537eb","volume":"7","author":"E Stiegel","year":"2013","unstructured":"Stiegel E, Say EA, Carter BC, Thomas MJ, Shields CL. Simultaneous fzd4 and lrp5 mutation in autosomal dominant familial exudative vitreoretinopathy. Retin Cases Brief Rep. 2013;7(1):26\u20138.","journal-title":"Retin Cases Brief Rep"},{"issue":"1","key":"2239_CR14","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1093\/genetics\/153.1.319","volume":"153","author":"RT Cox","year":"1999","unstructured":"Cox RT, Pai LM, Kirkpatrick C, Stein J, Peifer M. Roles of the C terminus of Armadillo in Wingless signaling in Drosophila. Genetics. 1999;153(1):319\u201332.","journal-title":"Genetics"},{"issue":"4","key":"2239_CR15","doi-asserted-by":"publisher","first-page":"468","DOI":"10.3109\/13816810.2015.1120318","volume":"37","author":"MW Dixon","year":"2016","unstructured":"Dixon MW, Stem MS, Schuette JL, Keegan CE, Besirli CG. CTNNB1 mutation associated with familial exudative vitreoretinopathy (FEVR) phenotype. Ophthalmic Genet. 2016;37(4):468\u201370.","journal-title":"Ophthalmic Genet"},{"key":"2239_CR16","first-page":"473","volume":"93","author":"WE Benson","year":"1995","unstructured":"Benson WE. Familial exudative vitreoretinopathy. Trans Am Ophthalmol Soc. 1995;93:473\u2013521.","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"1","key":"2239_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/eye.2014.70","volume":"29","author":"DF Gilmour","year":"2015","unstructured":"Gilmour DF. Familial exudative vitreoretinopathy and related retinopathies. Eye (Lond). 2015;29(1):1\u201314.","journal-title":"Eye (Lond)"},{"issue":"2","key":"2239_CR18","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.ejmg.2016.11.008","volume":"60","author":"M Kharbanda","year":"2017","unstructured":"Kharbanda M, Pilz DT, Tomkins S, Chandler K, Saggar A, Fryer A, et al. Clinical features associated with CTNNB1 de novo loss of function mutations in ten individuals. Eur J Med Genet. 2017;60(2):130\u20135.","journal-title":"Eur J Med Genet"},{"issue":"3","key":"2239_CR19","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1210\/clinem\/dgaa034","volume":"105","author":"H Peng","year":"2020","unstructured":"Peng H, Jenkins ZA, White R, Connors S, Hunter MF, Ronan A, et al. An activating variant in CTNNB1 is associated with a sclerosing bone dysplasia and adrenocortical neoplasia. J Clin Endocrinol Metab. 2020;105(3):688.","journal-title":"J Clin Endocrinol Metab"},{"issue":"18","key":"2239_CR20","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1001\/jama.2014.14604","volume":"312","author":"H Lee","year":"2014","unstructured":"Lee H, Deignan JL, Dorrani N, Strom SP, Kantarci S, Quintero-Rivera F, et al. Clinical exome sequencing for genetic identification of rare Mendelian disorders. JAMA. 2014;312(18):1880\u20137.","journal-title":"JAMA"},{"issue":"6","key":"2239_CR21","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/S0092-8674(04)00216-8","volume":"116","author":"Q Xu","year":"2004","unstructured":"Xu Q, Wang Y, Dabdoub A, Smallwood PM, Williams J, Woods C, et al. Vascular development in the retina and inner ear: control by Norrin and Frizzled-4, a high-affinity ligand-receptor pair. Cell. 2004;116(6):883\u201395.","journal-title":"Cell"},{"issue":"2","key":"2239_CR22","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.cell.2009.07.047","volume":"139","author":"X Ye","year":"2009","unstructured":"Ye X, Wang Y, Cahill H, Yu M, Badea TC, Smallwood PM, et al. Norrin, frizzled-4, and Lrp5 signaling in endothelial cells controls a genetic program for retinal vascularization. Cell. 2009;139(2):285\u201398.","journal-title":"Cell"},{"issue":"2","key":"2239_CR23","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1073\/pnas.0805165106","volume":"106","author":"R Daneman","year":"2009","unstructured":"Daneman R, Agalliu D, Zhou L, Kuhnert F, Kuo CJ, Barres BA. Wnt\/beta-catenin signaling is required for CNS, but not non-CNS, angiogenesis. Proc Natl Acad Sci USA. 2009;106(2):641\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"2239_CR24","doi-asserted-by":"publisher","first-page":"920","DOI":"10.3906\/sag-1308-100","volume":"44","author":"L Zhou","year":"2014","unstructured":"Zhou L, Deng L, Chang NB, Dou L, Yang CX. Cell apoptosis and proliferation in rat brains after intracerebral hemorrhage: role of Wnt\/beta-catenin signaling pathway. Turk J Med Sci. 2014;44(6):920\u20137.","journal-title":"Turk J Med Sci"},{"issue":"17","key":"2239_CR25","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1101\/gad.1686208","volume":"22","author":"T Grigoryan","year":"2008","unstructured":"Grigoryan T, Wend P, Klaus A, Birchmeier W. Deciphering the function of canonical Wnt signals in development and disease: conditional loss- and gain-of-function mutations of beta-catenin in mice. Genes Dev. 2008;22(17):2308\u201341.","journal-title":"Genes Dev"},{"issue":"8","key":"2239_CR26","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1242\/dev.128.8.1253","volume":"128","author":"V Brault","year":"2001","unstructured":"Brault V, Moore R, Kutsch S, Ishibashi M, Rowitch DH, McMahon AP, et al. Inactivation of the beta-catenin gene by Wnt1-Cre-mediated deletion results in dramatic brain malformation and failure of craniofacial development. Development. 2001;128(8):1253\u201364.","journal-title":"Development"},{"key":"2239_CR27","doi-asserted-by":"crossref","unstructured":"Gillespie RL, O'Sullivan J, Ashworth J, Bhaskar S, Williams S, Biswas S, et al. Personalized diagnosis and management of congenital cataract by next-generation sequencing. Ophthalmology. 2014;121(11):2124\u201337 e1\u20132.","DOI":"10.1016\/j.ophtha.2014.06.006"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-022-02239-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-022-02239-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-022-02239-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T13:32:25Z","timestamp":1646400745000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-022-02239-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,4]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2239"],"URL":"https:\/\/doi.org\/10.1186\/s13023-022-02239-3","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,4]]},"assertion":[{"value":"10 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study participant was recruited at Manchester Centre for Genomic Medicine as part of an ongoing study of inherited retinal degeneration in families without a molecular diagnosis following NGS screening for a panel of known genes (The UK Inherited Retinal Disease Consortium). Ethics committee approval was obtained for all aspects of this study (11\/NW\/0421 and 15\/YH\/0365) and the protocol observed the tenets of the Declaration of Helsinki. Written informed consent was obtained from the parents on behalf on the proband due to her young age, as an essential pre-requisite for study inclusion.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the parents of the proband for publication of the information contained within this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"110"}}